引用本文:胡 宽,段志华,周俊宇,汪子荃,王小辉,段文斌,段小辉,陈博滔.肝外胆管癌管理新规范:EASL指南核心推荐与临床实践要点[J].中国临床新医学,2026,19(5):506-511.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 87次   下载 24 本文二维码信息
码上扫一扫!
分享到: 微信 更多
肝外胆管癌管理新规范:EASL指南核心推荐与临床实践要点
胡 宽1,段志华1,周俊宇1,汪子荃2,王小辉1,段文斌1,段小辉1,陈博滔1
1.湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,长沙 410005;2.湖南师范大学医学部,长沙 410006
摘要:
[摘要] 《欧洲肝脏研究协会(EASL)肝外胆管癌管理临床实践指南》是2025年由涵盖病理学、放射学、肿瘤学及肝胆外科等领域的多学科专家小组,根据系统的循证研究和临床经验整合制订的权威指南。该指南涵盖肝外胆管癌的分类、流行病学、高危人群监测、诊断、治疗及随访等方面,详细阐述了从早期筛查到晚期姑息治疗的全程诊疗方案,为临床医师提供了全面且精准的参考依据。理解并借鉴该指南,将有助于提升我国肝外胆管癌的诊疗水平,为患者提供更高质量的医疗服务。
关键词:  肝外胆管癌  临床实践指南  分子分型  靶向治疗  免疫治疗
DOI:10.3969/j.issn.1674-3806.2026.05.02
分类号:R 735.8
基金项目:北京医学奖励基金会课题研究项目(编号:YX7L-2024-1700-0548);湖南省教育厅科学研究项目(编号:25C0014)
New standards for management of extrahepatic cholangiocarcinoma: core recommendations of EASL guidelines and key points in clinical practice
HU Kuan1, DUAN Zhihua1, ZHOU Junyu1, WANG Ziquan2, WANG Xiaohui1, DUAN Wenbin1, DUAN Xiaohui1, CHEN Botao1
1.Department of Hepatobiliary Surgery, the First Affiliated Hospital of Hunan Normal University, People′s Hospital of Hunan Province, Changsha 410005, China; 2.Hunan Normal University Health Science Center, Changsha 410006, China
Abstract:
[Abstract] European Association for the Study of the Liver(EASL) Clinical Practice Guidelines on the Management of Extrahepatic Cholangiocarcinoma is the authoritative guidelines formulated in 2025 by a multidisciplinary expert group covering pathology, radiology, oncology and hepatobiliary surgery, based on systematic evidence-based research and clinical experience integration. The guidelines cover a wide range of aspects of extrahepatic cholangiocarcinoma, including classification, epidemiology, monitoring of high-risk populations, diagnosis, treatment and follow-up, and elaborate in detail on the full course of diagnosis and treatment regimens from early screening to palliative care in the late stage, providing clinicians with comprehensive and precise reference. Understanding and drawing on the guidelines will help to improve the diagnosis and treatment of extrahepatic cholangiocarcinoma in China, and thereby providing the patients with higher-quality medical services.
Key words:  Extrahepatic cholangiocarcinoma(eCCA)  Clinical practice guidelines  Molecular typing  Targeted therapy  Immunotherapy